Rapamune - direct healthcare professional communication (DHPC)

sirolimus

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Rapamune (sirolimus) 1 mg/mL oral solution: restricted use of affected lots due to misalignment between expiry dates on the syringe adapter and oral solution

Key facts

• Medicine name:
  Rapamune
• Active substance:
  sirolimus
• Therapeutic area (MeSH):
  • Graft Rejection
  • Kidney Transplantation
• DHPC type:
  Quality defect
• Dissemination date:
  19/09/2025